Methotrexate blocks folate, which can lead to folate deficiency and complications like anemia. Folic acid can help reduce side effects of methotrexate, like nausea and mouth sores. Folic acid is ...
Researchers conducted a multicenter retrospective study involving 92 patients with methotrexate‑induced osteopathy to characterize the affected population, describe fracture patterns, and identify ...
Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognised useful secondary effect to lower blood pressure and potentially reduces the risk of heart disease in people ...
Disease-modifying drug therapies are being sought intensively for osteoarthritis (OA), but none have proved out thus far. A previous trial in patients with OA of the hand had found that methotrexate ...
Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted side effects. Now new research published at the ATS 2025 International ...
Researchers develop targeted polymersomes to enhance methotrexate delivery, offering a promising new approach for treating aggressive choriocarcinoma. Study: ENT-1-Targeted Polymersomes to Enhance the ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Delaying methotrexate initiation for 1 month after pneumococcal vaccination improves humoral ...
Methotrexate is a generic drug prescribed to treat certain types of cancers, arthritis, and psoriasis in adults and some children. As with other drugs, methotrexate can cause side effects, such as ...
Methotrexate (MTX) is a commonly used treatment option for managing refractory atopic dermatitis, especially as an alternative to cyclosporine, anti-interleukins, or anti-JAK treatments. According to ...
Methotrexate is a strong drug that could help clear up your psoriasis. It’s part of a class of medications called antimetabolites that stop cells from dividing and slow their growth. In psoriasis, ...
The findings add complexity to questions about the long-term impact of acute lymphoblastic leukemia (ALL) therapy. A new report shows high cumulative doses of intravenous methotrexate can have ...
Credit: Shorla Oncology. Jylamvo contains 2mg of methotrexate per mL and is packaged in bottles containing 60mL of oral solution. Jylamvo, a Food and Drug Administration (FDA)-approved oral solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results